Sudden Cardiac Death. An Essay for 2008
Section snippets
Prologue
Sudden cardiac death (SCD) has been an acquaintance, but not quite a friend, for nearly my entire professional life. Early in my career, in 1980, with my colleague and chief, Dr. Edward M. Dwyer, Jr., I planned a conference on Sudden Coronary Death sponsored by the New York Academy of Sciences. The conference was held in 1981 and published in 1982.1 Now, 25 years later, if not at the end, certainly late in my career, I am again participating in the planning of a symposium on Sudden Cardiac
The Stage
From a clinician's vantage point, sudden cardiac death can be trifurcated into distinct categories each of which requires unique insights into management and prevention.
The first category is that of the desperately sick heart. Initially the focus was limited to the coronary patient, defining high risk as prior aborted sudden death or easily induced malignant arrhythmia, but ultimately patients with an EF <30% due to myocardial infarction dominated the systematic enrollment into clinical trials.4
The Current Players
The bottom three steps of Myerburg's ziggurat embrace patients easiest to identify as SCD candidates, those with very sick hearts. Step 6, patients with an EF <30% and a prior myocardial infarction, are MADIT II patients4; step 4 patients, those with congestive heart failure and an EF <35%, are the population for SCD-Heft5 and for those patients with a prolonged QRS duration, the currently enrolling MADIT CRT.16 Patients in Step 5, those with prior out-of-hospital aborted sudden death or some
The Next Act
In the 1980's categories of risk were beginning to be defined and mechanisms were tentatively proposed. The search for mechanisms of SCD genesis and mechanisms of intervention was the dominant theme of the 1981 conference. Much of the focus was on electrical instability, but coronary spasm, platelet function, and autonomic nervous system dysfunction were all considered fruitful areas of inquiry. The intervention spotlight focused on drugs, although the ICD had begun to creep on to the stage.
References (39)
- et al.
Population-bases analysis of sudden cardiac death with and without left ventricular systolic dysfunction
J Am Coll Cardiol
(2006) - et al.
Familial Dilated Cardiomyopathy: Evidence for genetic and phenotypic heterogeneity
J Am Coll Cardiol
(1999) - et al.
Ten yeart trends of cardiovascular drug use after myocardial infarction among community-dwelling persons ≥65 years of age
Am J Cardiol
(2007) Genomics and cardiac arrhythmias
J Am Coll Cardiol
(2006)- et al.
Gene expression analysis of cardiovascular diseases
J Am Coll Cardiol
(2006) - et al.
Effects of statin therapy on arrhythmic events and survival in patients with non-ischemic dilated cardiomyopathy
J Am Coll Cardiol
(2006) - et al.
Effect of angiotensin enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction
J Am Coll Cardiol
(1999) - et al.
Paradoxical association of a group of atherosclerosis-related genotypes with reduced rate of coronary events after myocardial infarction
Am J Cardiol
(2005) - et al.
Sudden Coronary Death
Annals NY Acad Sci
(1982) - et al.
Implantable automatic defibrillator: their potential in preventing sudden coronary death
Annals NY Acad Sci
(1982)
Risk Stratification and Survival After Myocardial Infarction
New Eng J Med
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced EF
New Engl J Med
(SCH-Heft) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure
N Engl J Med
Genotype-phenotype correlations in the long-QT syndrome: gene-specifc triggers for life threatening arrhythmias
Circulation
Sudden death associated with short-QT syndrome linked to mutations in HERG
Circulation
Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome
Circulation
Role of genetic analysis in cardiology
Part 1: Mendelian diseases: cardiac channelopathies. Circulation
Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy
Circulation
Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy
Circulation
Cited by (3)
Benign cardiac tumours associated with sudden death
2014, EuropaceThe future of sudden cardiac death
2009, Annals of Noninvasive Electrocardiology